GB/T 18825-2024
Cyclopentane for industrial use
GB/T 18825-2024
GB/T 18825-2024
GB/T 18825-2024
GB/T 18825-2024
Cyclopentane for industrial use
GB/T 18825-2024
Commission Recommendation of 11 April 2006 on risk reduction measures for the substances: Dibutylphthalate; 3,4-Dichloroaniline; Di- isodecyl phthalate; 1,2-Benzenedicarboxylic acid, di-C 9-11 -branched alkyl esters, C 10 -rich; Di- isononyl phthalate; 1,2-Benzenedicarboxylic acid, di-C 8-10 -branched alkyl esters, C 9 -rich; Ethylenediaminetetraacetate; Methyl acetate; Monochloroacetic acid; n-Pentane; Tetrasodium ethylenediaminetetraacetate (Te
GB/T 18825-2024
Safety technical specifications for using cyclopentane as blowing agent in household and similar electrical appliances industry
GB/T 18825-2024
GB/T 18825-2024
Commission Implementing Regulation (EU) 2017/53 of 14 December 2016 concerning the authorisation of butan-1-ol, hexan-1-ol, octan-1-ol, nonan-1-ol, dodecan-1-ol, heptan-1-ol, decan-1-ol, pentan-1-ol, ethanol, acetaldehyde, propanal, butanal, pentanal, hexanal, octanal, decanal, dodecanal, nonanal, heptanal, undecanal, 1,1-diethoxyethane, formic acid, acetic acid, propionic acid, valeric acid, hexanoic acid, octanoic acid, decanoic acid, dodecanoi
GB/T 18825-2024
GB/T 18825-2024
Commission Regulation (EU) No 34/2013 of 16 January 2013 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for 2-phenylphenol, ametoctradin, Aureobasidium pullulans strains DSM 14940 and DSM 14941, cyproconazole, difenoconazole, dithiocarbamates, folpet, propamocarb, spinosad, spirodiclofen, tebufenpyrad and tetraconazole in or on certain products Text wi
GB/T 18825-2024
Determination of 4-(aminomethyl)cyclohexanecarboxylic acid(tranexamic Acid)in toothpaste—HPLC-MS/MS
GB/T 18825-2024
GB/T 18825-2024
Commission Regulation (EU) 2017/171 of 30 January 2017 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aminopyralid, azoxystrobin, cyantraniliprole, cyflufenamid, cyproconazole, diethofencarb, dithiocarbamates, fluazifop-P, fluopyram, haloxyfop, isofetamid, metalaxyl, prohexadione, propaquizafop, pyrimethanil, Trichoderma atroviride strain SC1 and z
GB/T 18825-2024
Commission Regulation (EU) 2016/1 of 3 December 2015 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for bifenazate, boscalid, cyazofamid, cyromazine, dazomet, dithiocarbamates, fluazifop-P, mepanipyrim, metrafenone, picloram, propamocarb, pyridaben, pyriofenone, sulfoxaflor, tebuconazole, tebufenpyrad and thiram in or on certain products (Text with EEA rel
GB/T 18825-2024
GB/T 18825-2024
GB/T 18825-2024
GB/T 18825-2024
5H-5-Methyl-6,7-dihydrocyclopenta[b]pyrazine
GB/T 18825-2024
Commission Regulation (EU) No 978/2011 of 3 October 2011 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid, biphenyl, captan, chlorantraniliprole, cyflufenamid, cymoxanil, dichlorprop-P, difenoconazole, dimethomorph, dithiocarbamates, epoxiconazole, ethephon, flutriafol, fluxapyroxad, isopyrazam, propamocarb, pyraclostrobin, pyrimethanil and s